This inventor holds 2 USPTO granted patents. Top assignee: The Mclean Hospital Corporation. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2018
Title: Anna Waclawa Sromek: Innovator in Aporphine Derivatives
Introduction
Anna Waclawa Sromek is a notable inventor based in Belmont, MA (US). She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work on aporphine derivatives. With a total of 2 patents, her inventions focus on compounds that have the potential to impact various medical conditions.
Latest Patents
Anna's latest patents include the development of 2-alkoxy-11-hydroxyaporphine derivatives. These compounds are designed to selectively bind to D-receptors, which are crucial in various neurological functions. The applications of these derivatives are promising, as they can be utilized for imaging D-receptors and for treating diseases such as Parkinson's disease, sexual dysfunction, and depressive disorders.
Career Highlights
Anna Waclawa Sromek is affiliated with the McLean Hospital Corporation, where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.
Collaborations
Some of her notable coworkers include John L. Neumeyer and Yu-Gui Si, who contribute to her research endeavors and collaborative projects.
Conclusion
Anna Waclawa Sromek is a pioneering inventor whose work on aporphine derivatives holds great promise for the future of medical treatments. Her contributions to the field are invaluable and continue to inspire advancements in medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile